Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001104659-23-007510

Options or other derivatives

  • HEAD OF R&D acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MODUR VIJAY · HEAD OF R&D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-25 Grant or award : show line 1 in the form Stock Options (Right to Buy) +30,000 30,000 D
Loading xslF345X03/tm234565-1_4seq1.xml…